NASDAQ · Drug Manufacturers - Specialty & Generic
COSM (COSM) Stock
$0.21
+3.75%
NASDAQ: COSM
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units
GlobeNewswire · Jul 20, 2026
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases
GlobeNewswire · Jul 17, 2026
Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases
GlobeNewswire · Jul 16, 2026
Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases
GlobeNewswire · Jul 15, 2026
Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases
GlobeNewswire · Jul 14, 2026
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About COSM
COSM is led by CEO Grigorios Siokas, employs 149 people, headquartered in US, publicly traded since 2010.
COSM stock trades at $0.21 with a market capitalization of $12.88M. The stock is valued at a price-to-earnings (P/E) ratio of -0.44, price-to-book of 0.80, price-to-sales of 0.19. Over the past 52 weeks the stock has ranged between $0.16 and $1.32, and currently trades 84.1% below its 52-week high.
On profitability, COSM generates a return on equity (ROE) of -105.56%, return on capital employed of -94.44%, an operating margin of -26.15%, a net profit margin of -30.41%.